Show Filters

Searches all publications.

Search Fulltext



Select publication to see the relevant sections.

Publication Date

    E.g., 2018-09-22
    E.g., 2018-09-22


51716 items
2:52 PM, Sep 18, 2018  |  BC Extra | Company News

Management tracks: BioTime, Immune-Onc

Degenerative disease company BioTime Inc. (NYSE-A:BTX; Tel Aviv:BTX) named Brian Culley CEO, to replace co-CEOs Adi Mohanty and Michael West. Most recently, Culley was CEO of infectious disease company Artemis Therapeutics Inc. (OTCQB:ATMS). Immunotherapy company Immune-Onc...
2:04 PM, Sep 18, 2018  |  BC Extra | Clinical News

Viking gains on Phase II NAFLD data

Viking Therapeutics Inc. (NASDAQ:VKTX) added $9.07 (87%) to $19.46 on Tuesday after reporting that VK2809 met the primary and secondary endpoints in a Phase II trial to treat non-alcoholic fatty liver disease. The move translates...
1:53 PM, Sep 18, 2018  |  BC Extra | Company News

Novo's R&D restructuring adds to innovation push

Four new R&D centers fueled by a dedicated business development unit and increased investment in machine learning and AI form the basis of an R&D restructuring announced by Novo Nordisk A/S (CSE:NOVO B; NYSE:NVO) on...
1:39 PM, Sep 18, 2018  |  BC Extra | Politics & Policy

Azar to head U.S. biodefense strategy

HHS will serve as the lead agency for implementing the U.S.’s biodefense strategy, with HHS Secretary Alex Azar tapped to chair a newly created cabinet-level biodefense steering committee, the White House announced Tuesday. The national security...
8:48 AM, Sep 18, 2018  |  BC Extra | Financial News

WuXi AppTec queues up for Hong Kong listing

Less than five months after its IPO in Shanghai, WuXi AppTec Co. Ltd. (Shanghai:603259) proposed Tuesday to list on the Hong Kong stock exchange in an offering underwritten by Morgan Stanley Asia, Huatai Financial Holdings...
8:17 AM, Sep 18, 2018  |  BC Extra | Financial News

Versant seeking $500M for seventh fund

Versant Ventures is targeting $500 million for Versant Venture Capital VII, according to an SEC filing. The firm declined to comment on the new fund. Versant invests in biotechs in the U.S., Canada and Europe. The...
4:37 PM, Sep 17, 2018  |  BC Extra | Tools & Techniques

AI code could speed cancer diagnosis, treatment decisions

New York University School of Medicine researchers described in Nature Medicine a machine learning-based program that can distinguish lung cancer subtypes and at least six driving mutations using only histological slide images, in less time...
4:29 PM, Sep 17, 2018  |  BC Extra | Politics & Policy

FDA to re-examine diabetes CVOT requirements

FDA is reconsidering its policy to require pre- and postmarket cardiovascular outcomes trials for diabetes drugs, and plans to hold an Oct. 24-25 meeting of its Endocrinologic and Metabolic Drugs Advisory Committee to discuss existing...
4:14 PM, Sep 17, 2018  |  BC Extra | Preclinical News

Brain lymphatics carry pathogenic T cells in MS

Blocking a signal that attracts pathogenic T cells to the brain’s lymphatic vessels could help treat multiple sclerosis, according to a Nature Neuroscience study. The findings add MS to a short but growing list of...
4:03 PM, Sep 17, 2018  |  BC Extra | Politics & Policy

Senate passes 'pay-for-delay' bill for biosimilars

The Senate passed a bill Monday that includes a provision to make it more difficult for branded drugmakers to strike “pay-for-delay” deals with biologic and biosimilar companies. The language aims to modernize reporting requirements for biologics...